Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene ExpressionDavid A. Jacobsohn, Michael A. Pulsipher, Lisa Eidenschink Brodersen et al.|Transplantation and Cellular Therapy|2018Cited by 44
Recent Thymic Emigrants and Tregs Expressing CD31 and CD45RA Are Decreased at Day 100 and Prognostic for Chronic GvHD in Children: Results From the Applied Biomarkers of Late Effects (ABLE)/Pediatric Blood and Marrow Transplant Consortium 1202 StudyGeoff D.E. Cuvelier, Kirk R. Schultz, Eneida R. Nemecek et al.|Transplantation and Cellular Therapy|2018Cited by 0